| RS80338867 |
WASHC5
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 8, Hereditary spastic paraplegia |
| RS80338869 |
SPG11
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia |
| RS80338877 |
TFR2
|
Health Risk |
Pathogenic |
Hemochromatosis type 3, Hereditary hemochromatosis |
| RS80338878 |
TFR2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hemochromatosis type 3, Hereditary hemochromatosis |
| RS80338879 |
TFR2
|
Health Risk |
Pathogenic |
Hemochromatosis type 3, Hereditary hemochromatosis |
| RS80338880 |
TFR2
|
Health Risk |
Pathogenic |
Hemochromatosis type 3, Hemochromatosis type 3 |
| RS80338882 |
TFR2
|
Health Risk |
Pathogenic |
Hemochromatosis type 3, Hereditary hemochromatosis |
| RS80338883 |
TFR2
|
Health Risk |
Likely pathogenic |
Hemochromatosis type 3, Hemochromatosis type 3 |
| RS80338884 |
TFR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hemochromatosis type 3, Hemochromatosis type 3 |
| RS80338885 |
TFR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hemochromatosis type 3, Hereditary hemochromatosis |
| RS80338888 |
TFR2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hemochromatosis type 3, Hereditary hemochromatosis |
| RS80338889 |
TFR2
|
Health Risk |
Pathogenic |
Hemochromatosis type 3, Hemochromatosis type 3 |
| RS80338890 |
TFR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hemochromatosis type 3, Hereditary hemochromatosis |
| RS80338891 |
TFR2
|
Health Risk |
Likely pathogenic |
Hemochromatosis type 3, Hereditary hemochromatosis |
| RS80338892 |
TH
|
Health Risk |
Pathogenic |
Autosomal recessive DOPA responsive dystonia, Autosomal recessive DOPA responsive dystonia |
| RS80338894 |
FAH
|
Health Risk |
Pathogenic |
Tyrosinemia type I, Tyrosinemia type II |
| RS80338895 |
FAH
|
Health Risk |
Pathogenic |
Tyrosinemia type I, FAH-related disorder |
| RS80338896 |
FAH
|
Health Risk |
Likely pathogenic |
Tyrosinemia type I, Tyrosinemia type I |
| RS80338897 |
FAH
|
Health Risk |
Pathogenic |
Tyrosinemia type I, Tyrosinemia type I |
| RS80338898 |
FAH
|
Health Risk |
Pathogenic/Likely pathogenic |
Tyrosinemia type I, FAH-related disorder |
| RS80338899 |
FAH
|
Health Risk |
Pathogenic |
Tyrosinemia type I, Tyrosinemia type I |
| RS80338900 |
FAH
|
Health Risk |
Pathogenic |
Tyrosinemia type I, Tyrosinemia type I |
| RS80338901 |
FAH
|
Health Risk |
Pathogenic/Likely pathogenic |
Tyrosinemia type I, FAH-related disorder |
| RS80338902 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa |
| RS80338903 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa |
| RS80338904 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa |
| RS80338905 |
VLDLR
|
Health Risk |
Pathogenic |
Cerebellar ataxia, intellectual disability |
| RS80338906 |
VLDLR
|
Health Risk |
Pathogenic |
Cerebellar ataxia, intellectual disability |
| RS80338907 |
VLDLR
|
Health Risk |
Pathogenic |
Cerebellar ataxia, intellectual disability |
| RS80338908 |
TEK
|
Health Risk |
Pathogenic |
Multiple cutaneous and mucosal venous malformations, Segmental undergrowth associated with venous malformation without capillary component |
| RS80338909 |
TEK
|
Health Risk |
Pathogenic |
Multiple cutaneous and mucosal venous malformations, Blue rubber bleb nevus |
| RS80338910 |
TFAP2B
|
Health Risk |
Pathogenic |
Char syndrome, Char syndrome |
| RS80338911 |
TFAP2B
|
Health Risk |
Pathogenic |
Char syndrome, Patent ductus arteriosus 2 |
| RS80338912 |
TFAP2B
|
Health Risk |
Pathogenic |
Char syndrome, Char syndrome |
| RS80338914 |
TFAP2B
|
Health Risk |
Pathogenic |
Char syndrome, Char syndrome |
| RS80338915 |
TFAP2B
|
Health Risk |
Pathogenic/Likely pathogenic |
Char syndrome, Char syndrome |
| RS80338917 |
TFAP2B
|
Health Risk |
Likely pathogenic |
Char syndrome, Char syndrome |
| RS80338920 |
SH3TC2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4C, Charcot-Marie-Tooth disease |
| RS80338921 |
SH3TC2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease type 4 |
| RS80338922 |
SH3TC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 4C, Charcot-Marie-Tooth disease |
| RS80338923 |
SH3TC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4C, Charcot-Marie-Tooth disease type 4 |
| RS80338924 |
SH3TC2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4C, Charcot-Marie-Tooth disease type 4C |
| RS80338925 |
SH3TC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 4C, Charcot-Marie-Tooth disease type 4 |
| RS80338926 |
SH3TC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 4C, Charcot-Marie-Tooth disease type 4 |
| RS80338929 |
SH3TC2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4C, Charcot-Marie-Tooth disease type 4 |
| RS80338930 |
SH3TC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease type 4 |
| RS80338931 |
SH3TC2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4C, Charcot-Marie-Tooth disease type 4 |
| RS80338932 |
SH3TC2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4C, Charcot-Marie-Tooth disease type 4 |
| RS80338933 |
SH3TC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 4C, Susceptibility to mononeuropathy of the median nerve |
| RS80338934 |
SH3TC2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4C, Charcot-Marie-Tooth disease type 4 |
| RS80338936 |
SH3TC2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4C, Charcot-Marie-Tooth disease type 4C |
| RS80338937 |
SH3TC2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4C, Charcot-Marie-Tooth disease type 4C |
| RS80338938 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1A, Charcot-Marie-Tooth disease type 2 |
| RS80338939 |
GJB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 1A, Deafness |
| RS80338940 |
GJB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 1A, Hearing impairment |
| RS80338941 |
GJB2
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 1A, Rare genetic deafness |
| RS80338942 |
GJB2
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 1A, Hearing impairment |
| RS80338943 |
GJB2
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 1A, Deafness |
| RS80338944 |
GJB2
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 1A, Rare genetic deafness |
| RS80338945 |
GJB2
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 1A, Hearing impairment |
| RS80338947 |
GJB2
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 1A, Hearing impairment |
| RS80338948 |
GJB2
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 1A, Hearing impairment |
| RS80338949 |
GJB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 1A, Nonsyndromic genetic hearing loss |
| RS80338950 |
GJB2
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 1A, Rare genetic deafness |
| RS80338955 |
SCN4A
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperkalemic periodic paralysis, Paramyotonia congenita of Von Eulenburg |
| RS80338956 |
SCN4A
|
Health Risk |
Likely pathogenic |
Paramyotonia congenita of Von Eulenburg, Hyperkalemic periodic paralysis |
| RS80338957 |
SCN4A
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperkalemic periodic paralysis, Paramyotonia congenita/hyperkalemic periodic paralysis |
| RS80338958 |
SCN4A
|
Health Risk |
Pathogenic/Likely pathogenic |
Paramyotonia congenita/hyperkalemic periodic paralysis, Hyperkalemic periodic paralysis |
| RS80338959 |
SCN4A
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperkalemic periodic paralysis, Hyperkalemic periodic paralysis |
| RS80338960 |
SCN4A
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperkalemic periodic paralysis, Hyperkalemic periodic paralysis |
| RS80338962 |
SCN4A
|
Health Risk |
Pathogenic |
Hyperkalemic periodic paralysis, Paramyotonia congenita/hyperkalemic periodic paralysis |
| RS80338963 |
SMAD4
|
Health Risk |
Pathogenic |
Generalized juvenile polyposis/juvenile polyposis coli, Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome |
| RS80338964 |
SMAD4
|
Health Risk |
Pathogenic |
Generalized juvenile polyposis/juvenile polyposis coli, Juvenile polyposis syndrome |
| RS80338965 |
SMAD4
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Generalized juvenile polyposis/juvenile polyposis coli |
| RS80344633 |
PDE6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital stationary night blindness autosomal dominant 2, Retinitis pigmentosa |
| RS80344795 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy |
| RS80345158 |
ALB
|
Health Risk |
Pathogenic |
— |
| RS80356459 |
SIX1
|
Health Risk |
Pathogenic |
Branchiootic syndrome 3, Autosomal dominant nonsyndromic hearing loss 23 |
| RS80356460 |
SIX1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal dominant nonsyndromic hearing loss 23, Branchiootic syndrome 3 |
| RS80356462 |
SIX5
|
Health Risk |
Conflicting classifications of pathogenicity |
Branchiootorenal syndrome 2, SIX5-related disorder |
| RS80356463 |
SIX5
|
Health Risk |
Pathogenic |
Branchiootorenal syndrome 2, Branchiootorenal syndrome 2 |
| RS80356469 |
SCN9A
|
Health Risk |
Pathogenic |
Primary erythromelalgia, Primary erythromelalgia |
| RS80356470 |
SCN9A
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary erythromelalgia, Primary erythromelalgia |
| RS80356471 |
SCN9A
|
Health Risk |
Pathogenic/Likely pathogenic |
SCN9A-related disorder, SCN9A-related disorder |
| RS80356473 |
SCN9A
|
Health Risk |
Likely pathogenic |
Primary erythromelalgia, Primary erythromelalgia |
| RS80356474 |
SCN9A
|
Health Risk |
Pathogenic |
Primary erythromelalgia, Acute episodes of neuropathic symptoms |
| RS80356475 |
SCN9A
|
Health Risk |
Pathogenic |
Primary erythromelalgia, Generalized epilepsy with febrile seizures plus |
| RS80356476 |
SCN9A
|
Health Risk |
Pathogenic |
Primary erythromelalgia, Primary erythromelalgia |
| RS80356478 |
SCN9A
|
Health Risk |
Pathogenic |
Primary erythromelalgia, Primary erythromelalgia |
| RS80356479 |
G6PC1
|
Health Risk |
Pathogenic |
Glycogen storage disease due to glucose-6-phosphatase deficiency type IA, Glycogen storage disease |
| RS80356482 |
G6PC1
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease due to glucose-6-phosphatase deficiency type IA, Glycogen storage disease |
| RS80356483 |
G6PC1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease due to glucose-6-phosphatase deficiency type IA, Glycogen storage disease due to glucose-6-phosphatase deficiency type IA |
| RS80356484 |
G6PC1
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease due to glucose-6-phosphatase deficiency type IA, Hepatocellular carcinoma |
| RS80356485 |
G6PC1
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease due to glucose-6-phosphatase deficiency type IA, Glycogen storage disease due to glucose-6-phosphatase deficiency type IA |
| RS80356486 |
G6PC1
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease due to glucose-6-phosphatase deficiency type IA, Glycogen storage disease due to glucose-6-phosphatase deficiency type IA |
| RS80356487 |
G6PC1
|
Health Risk |
Pathogenic |
Glycogen storage disease due to glucose-6-phosphatase deficiency type IA, Glycogen storage disease |
| RS80356488 |
G6PC1
|
Health Risk |
Pathogenic |
Glycogen storage disease due to glucose-6-phosphatase deficiency type IA, Glycogen storage disease |
| RS80356489 |
SLC37A4
|
Health Risk |
Pathogenic |
Glucose-6-phosphate transport defect, Glucose-6-phosphate transport defect |
| RS80356490 |
SLC37A4
|
Health Risk |
Pathogenic |
Glucose-6-phosphate transport defect, Glycogen storage disease |
| RS80356491 |
SLC37A4
|
Health Risk |
Pathogenic |
Phosphate transport defect, Glucose-6-phosphate transport defect |